(TCHP) T. Rowe Price Blue Chip - Overview
Etf: Technology, Healthcare, Consumer, Financials, Industrials
| Risk 5d forecast | |
|---|---|
| Volatility | 23.4% |
| Relative Tail Risk | 4.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | -8.05 |
| Character TTM | |
|---|---|
| Beta | 1.175 |
| Beta Downside | 1.154 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.92% |
| CAGR/Max DD | 1.22 |
Description: TCHP T. Rowe Price Blue Chip January 15, 2026
The T. Rowe Price Blue Chip Growth ETF (ticker TCHP) aims to invest at least 80 % of its net assets-plus any investment-purpose borrowings-into equities of large, well-established companies that the manager believes possess above-average earnings-growth potential.
Its portfolio concentrates on firms with leading market positions, seasoned management, and strong financial fundamentals; because the fund is classified as non-diversified, it typically holds fewer than 30 stocks, which raises concentration risk relative to broader ETFs.
Recent data (Q2 2024) show that technology accounts for roughly 45 % of the fund’s sector weighting, consumer discretionary about 20 %, and the average forward price-to-earnings ratio sits near 28×-a premium that reflects expectations of sustained growth. Key macro drivers include resilient consumer spending and ongoing corporate investment in cloud-computing infrastructure, both of which underpin earnings expansion for many of the holdings.
If you want a more granular, data-driven view of TCHP’s risk-adjusted performance and sector exposure, the free analytical tools on ValueRay can be a useful next step.
What is the price of TCHP shares?
Over the past week, the price has changed by -2.80%, over one month by -5.34%, over three months by -2.78% and over the past year by +8.74%.
Is TCHP a buy, sell or hold?
What are the forecasts/targets for the TCHP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55.7 | 17.1% |
TCHP Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.84b USD (1.84b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.84b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.84b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.25% (E(1.84b)/V(1.84b) * Re(10.25%) + (debt-free company))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)